[artículo] 
inJournal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 147-156

Título :	Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild alzheimer disease : A functional magnetic resonance imaging study
Tipo de documento:	texto impreso
Autores:	Arun L.W. Bokde, Autor ; Michaela Karmann, Autor ; Stefan J. Teipel, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 147-156
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Etiquetas:	Neurodegenerativo, Tratamiento colinérgico, Galantamina, RM farmacológica, Sistema visual, Enfermedad de Alzheimer
Resumen:	Visual perception has been shown to be altered in Alzheimer disease (AD) patients, and it is associated with decreased cognitive function. Galantamine is an active cholinergic agent, which has been shown to lead to improved cognition in mild to moderate AD patients.
Link:	./index.php?lvl=notice_display&id=29518

[artículo] Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild alzheimer disease : A functional magnetic resonance imaging study [texto impreso] / Arun L.W. Bokde, Autor ; Michaela Karmann, Autor ; Stefan J. Teipel, Autor . - 2022 . - pp. 147-156.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 147-156

Etiquetas:	Neurodegenerativo, Tratamiento colinérgico, Galantamina, RM farmacológica, Sistema visual, Enfermedad de Alzheimer
Resumen:	Visual perception has been shown to be altered in Alzheimer disease (AD) patients, and it is associated with decreased cognitive function. Galantamine is an active cholinergic agent, which has been shown to lead to improved cognition in mild to moderate AD patients.
Link:	./index.php?lvl=notice_display&id=29518